Therapy of congenital cytomegalovirus infection in children
In 90% of children congenital cytomegalovirus infection (CMV) proceeds latently. However, there is a high risk of developing severe clinical manifestations in the postnatal period. Since recombinant interferon drugs successfully used in obstetric practice for the prevention of vertical transmission...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Remedium Group LLC
2016-12-01
|
| Series: | Медицинский совет |
| Subjects: | |
| Online Access: | https://www.med-sovet.pro/jour/article/view/1261 |
| Summary: | In 90% of children congenital cytomegalovirus infection (CMV) proceeds latently. However, there is a high risk of developing severe clinical manifestations in the postnatal period. Since recombinant interferon drugs successfully used in obstetric practice for the prevention of vertical transmission of cytomegalovirus, we studied their effectiveness in the treatment of children with congenital CMV infection. Against the background of a prolonged regimen experienced rapid resolution of symptoms and the disappearance of an active CMV infection in the blood markers. During the clinical supervision of clinical episodes of reactivation of CMV infection in any of the observed child is not mentioned. |
|---|---|
| ISSN: | 2079-701X 2658-5790 |